Millipore Sigma Vibrant Logo

324831 EGF, Human, Recombinant, E. coli

EGF, Human, Recombinant, E. coli: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Epidermal Growth Factor, Human, Recombinant, E. coli

View This Product on Sigma-Aldrich
324831
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Purity
≥95% by SDS-PAGE

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
324831-200UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 200 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewRecombinant, human epidermal growth factor (54 amino acids) expressed in E. coli. Identical to human EGF except for an additional N-terminal methionine. Human EGF is 70% homologous to mouse EGF and has been shown to have similar biological activity. Mitogenic for a wide range of ectoderm- and endoderm-derived cells from tissue such as breast, cornea, epidermis, dermis, liver, pancreas, nerve, amnion, and adrenal medulla. Acts as a survival factor in preventing apoptosis.
      Catalogue Number324831
      Brand Family Calbiochem®
      SynonymsEpidermal Growth Factor, Human, Recombinant, E. coli
      References
      ReferencesMerlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.
      Product Information
      CAS number62229-50-9
      FormSolid
      FormulationLyophilized from sterile-filtered PBS.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 100-400 pg/ml as measured by its ability to stimulate the ³H-thymidine incorporation in an EGF-responsive mouse fibroblast cell line, Balb/3T3.
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/μg EGF
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKB4518000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C or -70°C) for long term storage or refrigerate (4°C) for short-term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C or -70°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      324831-200UGCN 04055977216189

      Documentation

      EGF, Human, Recombinant, E. coli (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      EGF, Human, Recombinant, E. coli 試験成績書（CoA）

      タイトルロット番号
      324831

      参考資料

      参考資料の概要
      Merlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-May-2008 RFH
      SynonymsEpidermal Growth Factor, Human, Recombinant, E. coli
      DescriptionRecombinant, human epidermal growth factor (54 amino acids) expressed in E. coli. Identical to native human EGF except for an additional N-terminal methionine. Human EGF is 70% homologous to mouse EGF and has been shown to have similar biological activity. Mitogenic for a wide range of ectoderm- and endoderm-derived cells from tissue such as breast, cornea, epidermis, dermis, liver, pancreas, nerve, amnion, and adrenal medulla. Binding of EGF to its 170 kDa transmembrane receptor results in dimerization of the receptor, activation of the intrinsic receptor tyrosine kinase, and initiation of the complex signal transduction cascade that leads to cell proliferation and/or differentiation. Acts as a survival factor in preventing apoptosis.
      FormSolid
      FormulationLyophilized from sterile-filtered PBS.
      CAS number62229-50-9
      RTECSKB4518000
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/μg EGF
      Biological activityED₅₀ = 100-400 pg/ml as measured by its ability to stimulate the ³H-thymidine incorporation in an EGF-responsive mouse fibroblast cell line, Balb/3T3.
      SolubilityReconstitute to a concentration of ≥10 µg/ml in 10 mM acetic acid containing ≥0.1% HSA or BSA.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C or -70°C) for long term storage or refrigerate (4°C) for short-term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C or -70°C.
      Toxicity Standard Handling
      Merck USA index14, 3527
      ReferencesMerlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.